Xijian Technology completes tens of millions of yuan Pre-A+round financing to build a globally leading human soft tissue mechanics imaging platform
Xijian Technology recently completed a pre-A+round of financing worth tens of millions of yuan, which is funded byYizhuang Capital leads the investment, Ruihua Capital follows suit, and old shareholder Yuanhui Chuangyi continues to increase investment.The funds raised in this round of financing will be used for product research and development, team expansion, and market promotion.
About Xijian
Xijian Technology is based on more than ten years of research foundation in the field of human soft tissue mechanics characterization in the Laboratory of Biomaterials and Soft Materials Mechanics at Tsinghua University, and is committed to promoting the industrialization of innovative technologies in human biomechanics theoryTo build a globally leading theoretical platform for human soft tissue mechanics.The company focuses on the blue ocean demand market in the health field such as sports rehabilitation, dermatology, and major disease diagnosis and treatment, providing the industry with world leading biological imaging equipment for human soft tissue mechanics (such as bones, skin, tumors, blood vessels, heart organs, etc.), and jointly building a human ecosystem based on the theory of human biomechanics.
About our partners
National Clinical Research Center for Orthopedics and Sports RehabilitationFormally approved by the Ministry of Science and Technology, the National Health Commission, the National Medical Products Administration, and the Logistics Support Department of the Military Commission in May 2019, it is currently a national medical, sports, and rehabilitation institutionNational level in the only fieldClinical medical research platform. The central supporting unit is the General Hospital of the People's Liberation Army, which carries the important mission and task of strengthening the construction of the medical technology innovation system and creating a new highland for national clinical medicine and translational research. The center has established a "medical, research, government, enterprise, and capital" integrated innovation ecosystem consisting of national agencies, national evaluation and testing institutions, departments, industrial parks, scientific research institutes, medical institutions, innovative enterprises, and capital institutions. It has created a full lifecycle innovation support platform that integrates demand collection, innovative research and development, trial production, product testing, clinical trials, registration and certification, clinical application, post market evaluation, technology promotion, and scientific popularization, exploring a new path for the development of innovative enterprises.
Yizhuang Capital (full name "Yizhuang Equity Investment Private Fund Management (Beijing) Co., Ltd.")Established in September 2020, it is the only private fund management institution for Yizhuang Holdings Group, the operator of the Industrial New City.Yizhuang Capital operates based on market-oriented principles, focusing on hard technology fields such as medical devices and advanced manufacturing, with a focus on investing in early-stage startups and long-term mutual growth.At present, we have invested in more than ten project companies.
Ruihua Business CapitalThe scope covers stock market investment, private equity, targeted issuance, (trust) funds, and financial derivatives business. The equity investment focuses on the fields of big health, new energy, semiconductors, etc., adhering to the Ruihua values of "purity, excellence, win-win, long-term preservation, and goodness", providing comprehensive value-added services for enterprises, and becoming a long-term strategic partner for enterprises.
Beijing Yuanhui Venture Capital Co., Ltd. (Yuanhui Chuangyi)Established in 2010, we seek and accompany passionate entrepreneurs and innovative enterprises with hard technology to grow together from a perspective; The basic concepts of "business for good" and "technology for the benefit of humanity" influence enterprises to undertake social responsibility; By innovating the redistribution of profits from business education, we will continue to empower public welfare. Yuanhuichuang focuses on investing in hard technology, with a particular emphasis on upstream industries in the life sciences (medical equipment/instruments, biological reagents, biomaterials, etc.) and advanced ICT industries (semiconductors, core modern components, materials, and basic software), with a significant focus on technology projects such as new energy and intelligent manufacturing.
